Newsroom
Jump to:
Press Releases
December 2, 2025
Truvian Secures FDA Clearance for TruVerus™, Setting a New Standard in Multimodal Blood Testing
Truvian today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance (K251058) for TruVerus™, the industry’s first multimodal blood testing benchtop instrument.
January 13, 2025
David P. King joins Truvian’s Advisory Board
Truvian today announced the appointment of David P. King to its Advisory Board. King brings decades of diagnostics and business experience with a distinguished track record of advancing innovation and shaping corporate strategy.
December 11, 2024
Truvian Health Appoints Dr. Tina Nova to its Board of Directors
Truvian announced the appointment of Tina S. Nova, Ph.D., to its Board of Directors. Dr. Nova has more than two decades of experience serving as an executive and board member in some of the most storied franchises in diagnostics and biotech.
